Previous 10 | Next 10 |
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N...
Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more ...
Synlogic (NASDAQ: SYBX ) and Ginkgo Bioworks announce a platform collaboration to accelerate expansion and development of Synlogic's pipeline of Synthetic Bioticmedicines using Ginkgo's cell programming platform for building and testing microbial strains to accelerate progression of early pr...
– Fuels development of Synlogic’s growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium – – Applies Ginkgo’s high-throughput synthetic biology platform services to human therapeutics –...
Aduro Biotech ( ADRO -42.2% ) slumps on a 4x surge in volume in response to data presented at ASCO on STING candidate ADU-S100. More news on: Aduro BioTech, Inc., Novartis AG, Synlogic, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Synlogic (NASDAQ: SYBX ) will collaborate with Roche ( OTCQX:RHHBY ) on clinical studies evaluating the combination of SYNB1891, a STING agonist, and Tecentriq (atezolizumab) in patients with advanced solid tumors. More news on: Synlogic, Inc., Roche Holding AG, Healthcare stocks news, ...
Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore Synlogic’s Synthetic Biotic™ medicine, SYNB1891...
Synlogic, Inc. (SYBX) Q1 2019 Results Earnings Conference Call May 09, 2019, 05:00 PM ET Company Participants Elizabeth Wolffe - Head, IR and Corporate Communications Aoife Brennan - President, CEO, and CMO Scott Plevy - CSO Todd Shegog - CFO Conference Call Participants ...
Synlogic (NASDAQ: SYBX ): Q1 GAAP EPS of -$0.51 beats by $0.02 . Revenue of $0.3M (-14.3% Y/Y) misses by $0.1M . Cash and equivalents of $109.8M. Press Release More news on: Synlogic, Inc., Earnings news and commentary, Healthcare stocks news, ,
– Company will host a conference call and webcast at 5:00 pm ET today – Synlogic, Inc. ( Nasdaq: SYBX ), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today reported its financial results for the first qu...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023. The Company...
CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today announced that its Board of Directors (the “Board”) has approved the adoption of a limited dur...
A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 97.9% to $0.23 on volume of 419,200,402 shares Sunworks Inc. (SUNW) rose 87.9% to $0.1022 on volume of 385,386,904 shares Green Giant Inc. (GGE) rose 15.4% to $0.0427 on volume of 208,454,257 s...